Delivery Order SPE2DB22D3004-SPE2DB24FQF35

Award Date 5/2/24
Potential Completion Date 5/3/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.14, is for the delivery of 4566422986 - LIDOCAINE 2% VISCOUS SOLN 100ML, with a completion date of November 14, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order worth $3,273.79 for LIDOCAINE 2% VISCOUS SOLN 100ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 27, 2025 and is a firm fixed price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. The contract is not designated as a...
This federal contract award, with ID SPE2DX15D3026|SPE2DX24FUWZB, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.91 firm fixed-price delivery order is for the supply of 4564793765 - LIDOCAINE HCL 2% LUER-JET 5ML, a medical product. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LIDOCAINE HCL 2% 200 MG/10 ML 10ML. The contract has a firm fixed price of $4,135.18 and a completion date of December 24, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,604.96 firm fixed-price contract is for the delivery of 4558761087 LIDOCAINE HCL 2% VIAL 5ML. The award has an ultimate completion date of October 14, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FV36K, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,034.28 firm fixed price delivery order is for the supply of 4562195302 - LIDOCAINE 2% VISCOUS SOLN 100ML, with a completion date of September 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery order SPE2DX24F54S9, valued at $1,275.49, to supply 4565330507 - LIDOCAINE 0.4% IN D5W SOLN 500ML to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The delivery order is a Firm Fixed Price contract with an ultimate completion date of August 5, 2024. This contract is not set aside for any specific business type. Amerisourcebergen is a major pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,079.70 and a performance period ending on January 13, 2025. The contract is for the delivery of LIDOCAINE HCL 2% 200 MG/10 ML 10ML, a medical supply item. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
The federal contract award SPE2DB22D1106|SPE2DB25FDUT6 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,352.05, is for the delivery of 4566960442 - LIDOCAINE 2% VISCOUS SOLN 100ML. This is a firm fixed price delivery order contract with an ultimate completion date of January 17, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 2% viscous solution in 100ml quantities. The $2,178.33 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQF35
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of LIDOCAINE 2% VISCOUS 15 ML CUP UD 15ML to the U.S. Defense Logistics Agency (DLA). The $1,143.55 firm fixed-price delivery order contract has a completion date of May 3, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific order does not have a set-aside designation.

Generated 8/1/24, 10:24 AM